Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer
Sera Lim, Yesol Kim, Soo Been Lee, Hyeok Gu Kang, Da Hyun Kim, Jee Won Park, Daeun Chung, Hyunkyung Kong, Kyung Hyun Yoo, Yonghwan Kim, Wonshik Han, Kyung Hee Chun, Jong Hoon Park
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer'. Together they form a unique fingerprint.